{
    "title": "US FDA advisers to weigh full approval for Eisai-Biogen's Alzheimer's drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11956973/US-FDA-advisers-weigh-approval-Eisai-Biogens-Alzheimers-drug.html",
    "date": "2023-04-10",
    "keywords": [
        "drug",
        "approval",
        "fda",
        "june",
        "leqembi",
        "disease",
        "food",
        "administration",
        "meeting",
        "co",
        "ltd",
        "biogen",
        "inc",
        "filing",
        "january",
        "mindwasting",
        "health",
        "regulator",
        "trial",
        "infusion",
        "rate",
        "decline",
        "placebo",
        "data",
        "study",
        "class",
        "advance",
        "toxic",
        "protein",
        "beta",
        "amyloid",
        "brain",
        "reporting",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}